Why do I have confusion with yellow skin?

Confusion with yellow skin typically indicates jaundice from elevated bilirubin levels, often due to liver dysfunction, which can cause hepatic encephalopathy affecting brain function. Immediate medical evaluation is essential as this combination suggests serious conditions requiring prompt treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Connection Between Yellow Skin and Confusion

Experiencing confusion alongside yellowing of the skin is a serious medical concern that requires immediate attention. This combination of symptoms typically points to significant liver dysfunction, where the organ's inability to process toxins affects both your appearance and cognitive function. The yellow discoloration, known as jaundice, occurs when bilirubin builds up in your bloodstream, while the confusion often results from toxins affecting your brain that would normally be filtered by a healthy liver.

When your liver cannot properly function, it creates a cascade of problems throughout your body. The same dysfunction that causes bilirubin to accumulate and turn your skin yellow also allows other harmful substances, particularly ammonia, to build up in your blood. These toxins can cross the blood-brain barrier and interfere with normal brain function, leading to confusion, disorientation, and other cognitive symptoms. This condition, known as hepatic encephalopathy, represents a medical emergency that requires prompt evaluation and treatment.

What Causes Jaundice and Mental Confusion Together

The simultaneous occurrence of jaundice and confusion typically stems from severe liver disease or acute liver failure. Your liver performs over 500 vital functions, including filtering toxins from your blood, producing proteins necessary for blood clotting, and processing bilirubin from broken-down red blood cells. When liver function becomes severely compromised, multiple systems in your body begin to fail, manifesting as both visible changes like yellowing skin and neurological symptoms like confusion.

Stages of Hepatic Encephalopathy (West Haven Criteria)

Progression through stages can be rapid in acute liver failure or gradual in chronic disease.
StageLevel of ConsciousnessCognitive SymptomsNeurological Signs
Stage 0 (Minimal)Stage 0 (Minimal)NormalSubtle cognitive deficits only on testingNone apparent
Stage 1Stage 1Mild lack of awarenessShortened attention span, impaired calculationsMild asterixis, altered sleep patterns
Stage 2Stage 2Lethargy, apathyDisorientation to time, obvious personality changeObvious asterixis, slurred speech
Stage 3Stage 3Somnolence to semi-stuporGross disorientation, bizarre behaviorMuscular rigidity, clonus, hyperreflexia
Stage 4Stage 4ComaNo response to verbal stimuliDecerebrate posturing possible

Progression through stages can be rapid in acute liver failure or gradual in chronic disease.

Acute Liver Failure

Acute liver failure can develop rapidly, sometimes within days or weeks, in people without pre-existing liver disease. Common causes include acetaminophen overdose, viral hepatitis (particularly hepatitis A, B, or E), autoimmune hepatitis, or reactions to certain medications or herbal supplements. The rapid deterioration of liver function leads to a quick buildup of toxins, causing both jaundice and hepatic encephalopathy. Patients may progress from mild confusion to coma within hours or days without treatment.

Chronic Liver Disease Progression

In chronic liver disease, such as cirrhosis from alcohol use, chronic hepatitis B or C, or non-alcoholic fatty liver disease, the development of confusion with jaundice often signals disease progression or an acute decompensation event. Years of liver damage lead to scarring and reduced function, but the body often compensates until a triggering event like infection, gastrointestinal bleeding, or dehydration pushes the liver beyond its capacity. Understanding your liver health through regular monitoring of biomarkers like ALT, AST, bilirubin, and albumin can help detect problems before they become critical.

Biliary Obstruction with Complications

Blockage of the bile ducts from gallstones, tumors, or strictures can cause jaundice by preventing bilirubin excretion. While simple obstruction typically doesn't cause confusion, complications like ascending cholangitis (infection of the bile ducts) can lead to sepsis, which affects brain function. The combination of high fever, jaundice, and confusion, known as Reynolds' pentad when accompanied by shock and abdominal pain, represents a life-threatening emergency requiring immediate intervention.

Recognizing Hepatic Encephalopathy Stages

Hepatic encephalopathy, the brain dysfunction that occurs with liver failure, progresses through distinct stages. Early recognition allows for prompt treatment that can prevent progression to more severe stages. Healthcare providers use the West Haven Criteria to classify the severity of hepatic encephalopathy, which helps guide treatment decisions and prognosis.

The progression through these stages can be rapid or gradual, depending on the underlying cause and precipitating factors. Patients in early stages may have subtle changes that family members notice before the patient does, such as sleep pattern reversal, mild forgetfulness, or personality changes. As the condition worsens, more obvious symptoms like tremor (asterixis), disorientation, and eventually stupor or coma develop.

Critical Warning Signs Requiring Emergency Care

Certain symptoms accompanying confusion and jaundice indicate the need for immediate emergency medical attention. These warning signs suggest rapid deterioration that could be life-threatening without prompt intervention:

  • Sudden onset of severe confusion or inability to recognize familiar people
  • Difficulty staying awake or arousing from sleep
  • Slurred speech or difficulty forming coherent sentences
  • Trembling hands or involuntary flapping movements (asterixis)
  • Severe abdominal pain or swelling
  • Vomiting blood or passing black, tarry stools
  • High fever with chills and rigors
  • Rapid breathing or shortness of breath
  • Decreased urine output or dark brown urine
  • Swelling in legs and abdomen (ascites)

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Tests and Biomarkers

When presenting with confusion and jaundice, healthcare providers will order comprehensive testing to determine the underlying cause and severity of liver dysfunction. Blood tests form the cornerstone of diagnosis, measuring liver enzymes, bilirubin levels, ammonia, and markers of synthetic function. Understanding these biomarkers helps doctors assess the extent of liver damage and guide treatment decisions.

Essential Blood Tests

Key laboratory tests include complete blood count, comprehensive metabolic panel, liver function tests (ALT, AST, alkaline phosphatase, GGT), bilirubin (total and direct), albumin, prothrombin time/INR, and ammonia levels. Additional tests may include viral hepatitis panels, autoimmune markers, ceruloplasmin (for Wilson's disease), and alpha-1 antitrypsin levels. These tests help differentiate between various causes of liver dysfunction and assess the severity of liver failure.

Imaging and Additional Studies

Imaging studies such as ultrasound, CT, or MRI help visualize the liver structure, identify masses or obstructions, and assess for complications like ascites or portal vein thrombosis. In some cases, liver biopsy may be necessary to determine the exact cause of liver disease. Electroencephalography (EEG) can help assess the severity of hepatic encephalopathy by detecting characteristic brain wave changes.

Treatment Approaches for Liver-Related Confusion

Treatment for confusion with jaundice focuses on addressing both the underlying liver disease and managing the hepatic encephalopathy. The approach varies depending on whether the liver failure is acute or chronic, the severity of symptoms, and the presence of precipitating factors. Immediate interventions aim to reduce toxin levels, particularly ammonia, while supporting overall liver function.

Lactulose, a synthetic sugar that helps remove ammonia through the intestines, serves as the first-line treatment for hepatic encephalopathy. Patients typically receive doses every few hours until bowel movements occur, then maintenance dosing to achieve 2-3 soft stools daily. Rifaximin, an antibiotic that reduces ammonia-producing bacteria in the gut, often supplements lactulose therapy. For acute liver failure, more aggressive measures including dialysis, plasma exchange, or emergency liver transplantation may be necessary.

Addressing Precipitating Factors

Identifying and treating precipitating factors is crucial for managing hepatic encephalopathy. Common triggers include infections (particularly spontaneous bacterial peritonitis in cirrhotic patients), gastrointestinal bleeding, dehydration, electrolyte imbalances, constipation, and certain medications. Correcting these factors often leads to rapid improvement in mental status. Patients may need antibiotics for infections, blood products for bleeding, or intravenous fluids for dehydration.

Prevention and Long-term Management Strategies

For individuals with chronic liver disease, preventing episodes of hepatic encephalopathy requires ongoing management and lifestyle modifications. Regular monitoring of liver function, adherence to medications, and avoiding precipitating factors form the foundation of prevention. Patients should work closely with hepatologists to optimize their treatment regimen and recognize early warning signs of decompensation.

Dietary modifications play a crucial role in managing chronic liver disease. While protein restriction was once standard, current guidelines recommend maintaining adequate protein intake (1.2-1.5 g/kg/day) with emphasis on vegetable and dairy proteins over red meat. Branched-chain amino acid supplements may benefit some patients. Sodium restriction helps manage fluid retention, while avoiding alcohol is essential for preventing further liver damage. Regular monitoring through comprehensive blood testing can help track liver function and catch problems early.

If you're experiencing any combination of confusion and yellowing skin, don't wait to seek medical attention. These symptoms together indicate a serious medical condition requiring immediate evaluation. For those with known liver disease or risk factors, consider using SiPhox Health's free blood test analysis service to better understand your liver function markers and receive personalized insights about your health status. Early detection and management of liver problems can prevent progression to life-threatening complications.

Taking Action for Your Liver Health

The combination of confusion and yellow skin represents a medical emergency that requires immediate professional evaluation. While this article provides important information about potential causes and treatments, it cannot replace proper medical assessment. If you or someone you know experiences these symptoms, call emergency services or go to the nearest emergency room immediately. Time is critical when dealing with acute liver dysfunction, and early intervention can be life-saving.

For those concerned about their liver health or with risk factors for liver disease, proactive monitoring through regular blood testing can help detect problems before they become severe. Understanding your baseline liver function values and tracking changes over time empowers you to work with your healthcare team to maintain optimal liver health and prevent serious complications.

References

  1. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715-735.[Link][DOI]
  2. Flamm SL. Acute Liver Failure. Clin Liver Dis. 2023;27(2):301-315.[PubMed][DOI]
  3. Rose CF, Amodio P, Bajaj JS, et al. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73(6):1526-1547.[Link][DOI]
  4. Tapper EB, Jiang ZG, Patwardhan VR. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy. Mayo Clin Proc. 2015;90(5):646-658.[PubMed][DOI]
  5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J Hepatol. 2022;77(3):807-824.[Link][DOI]
  6. Stravitz RT, Lee WM. Acute liver failure. Lancet. 2019;394(10201):869-881.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my liver function biomarkers at home?

You can test your liver function at home with SiPhox Health's Heart & Metabolic Program, which includes essential liver enzymes ALT, AST, and bilirubin testing. This CLIA-certified program provides comprehensive metabolic health insights from the comfort of your home.

What bilirubin level causes visible jaundice?

Jaundice typically becomes visible when total bilirubin levels exceed 2.5-3.0 mg/dL. The yellowing usually appears first in the whites of the eyes (scleral icterus) before becoming noticeable in the skin. Normal bilirubin levels are typically below 1.2 mg/dL.

Can hepatic encephalopathy be reversed?

Yes, hepatic encephalopathy can often be reversed with proper treatment, especially when precipitating factors are identified and corrected. Treatment with lactulose and rifaximin, along with managing underlying liver disease, can significantly improve or resolve confusion. However, repeated episodes may cause permanent cognitive changes.

What's the difference between acute and chronic liver failure symptoms?

Acute liver failure develops rapidly (days to weeks) with sudden onset of jaundice, confusion, and coagulopathy in someone without prior liver disease. Chronic liver failure develops over months to years with gradual symptom progression, often with periods of stability interrupted by acute decompensation events.

Should I go to the emergency room for yellow skin and confusion?

Yes, the combination of yellow skin and confusion is a medical emergency requiring immediate evaluation. These symptoms together suggest serious liver dysfunction that can rapidly worsen without treatment. Call 911 or go to the nearest emergency room immediately.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details